MedKoo Cat#: 575129 | Name: Ergotamine tartrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ergotamine is a vasoconstrictor that acts as an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders. This product is a controlled substance. It is not available.

Chemical Structure

Ergotamine tartrate
Ergotamine tartrate
CAS#379-79-3 (tartrate)

Theoretical Analysis

MedKoo Cat#: 575129

Name: Ergotamine tartrate

CAS#: 379-79-3 (tartrate)

Chemical Formula: C70H76N10O16

Exact Mass: 1312.5441

Molecular Weight: 1313.43

Elemental Analysis: C, 64.01; H, 5.83; N, 10.66; O, 19.49

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Avetol; Ergotamine bitartrate; Ergotamine hemitartrate; Ergotamine tartrate; Gotamine tartrate; Migretamine; NSC 95090; NS- 95090; NSC95090;
IUPAC/Chemical Name
Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
InChi Key
CJMJLDQKTOJACI-BGQAIRJTSA-N
InChi Code
InChI=1S/2C33H35N5O5.C4H6O6/c2*1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h2*3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t2*21-,25-,26+,27+,32-,33+;1-,2-/m111/s1
SMILES Code
[H][C@@]12CC3=CNC4=C3C(C1=C[C@@H](C(N[C@@]5(C)C(N6[C@@H](CC7=CC=CC=C7)C(N8CCC[C@]8([C@]6(O)O5)[H])=O)=O)=O)CN2C)=CC=C4.[H][C@@]9%10CC%11=CNC%12=C%11C(C9=C[C@@H](C(N[C@@]%13(C)C(N%14[C@@H](CC%15=CC=CC=C%15)C(N%16CCC[C@]%16([C@]%14(O)O%13)[H])=O)=O)=O)CN%10C)=CC=C%12.O=C(O)[C@H](O)[C@@H](O)C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,313.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Zajdel P, Bednarski M, Sapa J, Nowak G. Ergotamine and nicergoline - facts and myths. Pharmacol Rep. 2015 Apr;67(2):360-3. doi: 10.1016/j.pharep.2014.10.010. Epub 2014 Oct 30. PMID: 25712664. 2. Lipton RB. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles. Headache. 1997;37 Suppl 1:S33-41. PMID: 9009472. 3. Waters WE. Ergotamine tartrate in migraine. Br Med J. 1970 Jul 18;3(5715):164. doi: 10.1136/bmj.3.5715.164-b. PMID: 4914437; PMCID: PMC1702260.